GENEWIZ from Azenta Life Sciences

GENEWIZ, a brand under Azenta Life Sciences, is a global leader in multiomics and synthetic solutions services. Founded in 1999, the company specializes in high-quality genomics services, including next-generation sequencing (NGS), Sanger sequencing, and gene synthesis. GENEWIZ supports a wide range of institutions, such as academic, pharmaceutical, biotechnology, government, and healthcare organizations, by providing precision-based solutions that enhance research progress in drug development, clinical research, and advanced cell therapies. The company offers a comprehensive portfolio of services, including various sequencing options, gene synthesis, and specialized compliant services. GENEWIZ also provides clinical and preclinical support, ensuring adherence to regulatory standards. Their emerging solutions include AAV gene therapy services, which focus on transgene expression cassettes and long-read sequencing. With a commitment to superior data quality and fast turnaround times, GENEWIZ positions itself as a trusted partner for leading organizations in diverse fields, including agriculture, cancer research, and synthetic biology.